Home > D. General pathology > Genetic and developmental anomalies > Genetic metabolic diseases > homocystinuria
homocystinuria
MIM.236200 21q22.3
Friday 1 August 2008
Definition: Homocystinuria is a autosomal recessive metabolic disorder due to cystathionine beta-synthase (EC 4.2.1.22) deficiency producing increased urinary homocystine and methionine. Major clinical manifestations involve the eyes and the central nervous, skeletal, and vascular systems.
Clinical synopsis
normal to tall stature
occasional failure to thrive in infancy
ectopia lentis
myopia
glaucoma
ectopia lentis (90%)
high arched palate
crowded teeth
myocardial infarction
mitral valve prolapse
pectus excavatum
pectus carinatum
nearsightedness
flush across the cheeks
tall, thin build
long limbs
high-arched feet (pes cavus)
knock-knees (genu valgum)
mental retardation
psychiatric disease
myopia
optic atrophy
seizure
extensive atheroma formation at young age which affects many arteries but not the coronary arteries
inguinal hernia
fatty changes in liver
pancreatitis
generalized osteoporosis
biconcave ’codfish’ vertebrae
kyphoscoliosis
oolichostenomelia
arachnodactyly
limited joint mobility
fine, brittle hair
seizures
cerebrovascular accident
thromboembolism
LABORATORY
homocystinuria
methioninuria
Etiology
cystathionine beta-synthase deficiency
Therapeutis and management
Fifty-percent of individuals responsive to pyridoxine (vitamin B6)
Pyridoxine responsive individuals often have milder manifestations than those not responsive
Management of homocystinuria includes low methionine, cystine supplemented diet for pyridoxine nonresponders and pyridoxine supplementation for pyridoxine responders
Treatment with betaine, especially for pyridoxine nonresponders.